SEC
SlamSEC
SearchBrowseEarnings

Replimune Group, Inc.

Nasdaq:REPL
Biological Products, (No Diagnostic Substances)·WOBURN, MA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Credit & Agreementsmaterial agreements · debt obligations

Credit & Agreements (8-K)

10 shown
FiledDescription
2/3/26
1.012.03
Material Agreement · New Debt Obligation
→
3/7/25
1.01
Material Agreement
→
6/13/24
1.01
Material Agreement
→
12/26/23
1.012.03
Material Agreement · New Debt Obligation
→
8/3/23
1.011.02
Material Agreement · Agreement Terminated
→
10/7/22
1.012.03
Material Agreement · New Debt Obligation
→
↓ 4 more
CEO
Patel Sushil
CFO
Hill Emily Luisa